<< Back to Results
Window of opportunity study targeting the inflammatory milieu of pregnancy associated breast cancer
- A clinical trial with fish oil capsules and the COX-2 inhibitor celecoxib, taken orally, in pregnancy associated breast cancer (PABC).
- IRB Protocol Number
- Principal Investigator(s)
- VIRGINIA BORGES
- EMILY ROZZO at
- Eligibility and Other Participant Information
- What To Expect : A screening period to determine eligibility. A treatment period lasting 1 or more weeks until surgery. You will be asked to come in to the clinic for follow-up 1 week after surgery. // Eligibility criteria include but are not limited to patients 18 years or older who have newly diagnosed invasive breast cancer.